Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
CNW/ - Pharmascience Canada is proud to announce the launch of Pr pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...
TheraSyn Bio and Rubix LS have announced a groundbreaking joint venture, Project Panacea, to develop a topical breast cancer therapy.
Is cannabis use during pregnancy safe? No, the use of tetrahydrocannabinol (THC) and cannabidiol (CBD) may affect your baby's ...
People unconsciously cheat to feel smarter or healthier, deceiving themselves into believing their success is due to ability ...
The surge of Anti-Obesity Medications is reshaping eating habits and opening new opportunities for the food industry to ...
Explore how psychosocial and physical stress affects cfDNA release in blood and saliva. Discover gender differences and ...
Test your knowledge on biomarkers and molecular markers, their roles in health, disease, and treatment response in this ...
Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according to Technavio. The market is estimated to ...
Report on how AI is driving market transformation - The global nano positioning systems market size is estimated to grow by USD 183.95 million from 2024-2028, according to Technavio. The market is ...
A groundbreaking policy that addresses women's holistic health and wellness Offers two covers: Vita Shield and Cradle Care First-of-its-kind coverage that includes ...
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Omvoh works to reduce inflammation within the gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results